Press release
Use of AI in Drug Development to Drive the Cancer Supportive Care Products Market
The Cancer Supportive Care Products Market is all set to go great guns in the forecast period. Big data makes way for real-time data visualization, thereby identifying the high-risk populations. Healthcare organizations are into sharing more data. This creation and collection of bigger datasets are likely to increase precision and help organizations in spotting trends. These trends are expected to keep the entire healthcare vertical on the toes.An up-to-date business publication by Persistence Market Research notifies that the shares in the global cancer supportive care products market is consolidated among a handful of players. There are only a few companies that can be ascribed as market leaders whereas the competition is much stiff among mid-level and emerging players. Hoffman LA-Roche, Novartis AG, Amgen, Baxter, and Teva Pharmaceuticals are a few notable names in the market for cancer supportive care products.
Most of these players are enhancing their business operations in international markets by launching new products. In addition to this, making equity investments in companies that have the potential to devise niche technologies, expanding into emerging economies to tap new customers, and indulging in mergers and acquisitions are some of the other strategies frequently adopted by these players.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/5336
Company Profiles:
Amgen Inc.
Johnson & Johnson.
Novartis Ag.
Baxter International Inc.
Fagron Group BV.
Teva Pharmaceuticals Industries Ltd.
Hoffmann LA- Roche Inc.
APR Applied Pharma Science Research S.A.
Acacia Pharma Ltd.
Kyowa Hakko Kirin Co Ltd.
Other.
Get A Customized Scope To Match Your Need Ask An Expert - sales@persistencemarketresearch.com
Global Cancer Supportive Care Products Market to be Worth US$ 31,700.0 Mn by 2021
As the PMR report foresees the future of the cancer supportive care products market, the demand will expand at a notable CAGR of 4.8% during the forecast period of 2017 to 2021. In terms of revenue, the concerned market is poised to attain a valuation of US$ 31,700.0 Mn by the end of 2021, considerably more than its evaluated 2017 worth of US$ 26,285.5 Mn in 2017.
For critical insights, request for methodology @ https://www.persistencemarketresearch.com/methodology/5336
On the basis of drug class, the report segments the market for cancer supportive care products into nonsteroidal erythropoietin stimulating agents, opioid analgesics, anti-imflammatory drugs, anti-infective drugs, bisphosphonates, anti-emetics drugs, monoclonal antibodies, and granulocyte colony stimulating factor. Indication-wise, the market has been bifurcated into lung cancer, prostate cancer, breast cancer, leukemia, ovarian cancer, bladder cancer, liver cancer, melanoma, and others.
Chronicity of Cancer Driving Demand
The strong prevalence of cancer and the chronicity of the disease is the primary driver of the global cancer supportive care products market. There will be nearly 24 million cancer patients across the world by 2035 according to a recent report by the WCRF and most of them will need care for quite a number of years as cancer does not cause sudden death in most cases. A number of healthcare organizations have recognized the escalating demand from cancer patients and are opening specialized care centers as well as investing in the research and development of products that serve them adequately. Some of the other factors augmenting demand in the global cancer supportive care products market are: increasing geriatric population who are more prone to the disease, greater effectiveness of anti-cancer treatments, rising prevalence of several forms of cancer, high demand for improved cancer supportive care therapies, increasing focus on maintaining superior quality of life, and availability in alternative dosage forms in compounding pharmacies.
On the other hand, loss of brand exclusivity of various generic drugs, entry of biosimilars, rising costs of innovation holding R&D investments, and regulatory barriers are some of the key factors restraining the cancer supportive care products market. Therefore, lack of blockbuster drugs would mean that in the next five years, the market would be defined in part by development of new formulas, combinations, and delivery devices.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5336
That being said, the report also notifies of a few opportunities such as emerging products and therapeutic areas and high investment for R&D by pharmaceutical companies. Some of the trends of this market include a growing focus on biosimilars, a highly competitive environment that is egged to escalate care to cancer patients, and merger and acquisition activities by major players.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/cancer-supportive-care-products-market.asp
Read More Trending "PMR Exclusive Article"-
Meningococcal Vaccines Market@ https://www.persistencemarketresearch.com/market-research/meningococcal-vaccines-market.asp
Osteoarthritis Market@ https://www.persistencemarketresearch.com/market-research/osteoarthritis-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on "micros" by Persistence Market Research helps companies overcome their "macro" business challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Use of AI in Drug Development to Drive the Cancer Supportive Care Products Market here
News-ID: 2561969 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…